These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 8609284)

  • 1. Latency and multiple sources of distortion product otoacoustic emissions.
    Stover LJ; Neely ST; Gorga MP
    J Acoust Soc Am; 1996 Feb; 99(2):1016-24. PubMed ID: 8609284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Locus of generation for the 2f1-f2 vs 2f2-f1 distortion-product otoacoustic emissions in normal-hearing humans revealed by suppression tuning, onset latencies, and amplitude correlations.
    Martin GK; Jassir D; Stagner BB; Whitehead ML; Lonsbury-Martin BL
    J Acoust Soc Am; 1998 Apr; 103(4):1957-71. PubMed ID: 9566319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multicomponent acoustic distortion product otoacoustic emission phase in humans. II. Implications for distortion product otoacoustic emissions generation.
    Moulin A; Kemp DT
    J Acoust Soc Am; 1996 Sep; 100(3):1640-62. PubMed ID: 8817892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase delay measurements of distortion product otoacoustic emissions at 2f1-f2 and 2f2-f1 in human ears.
    Wable J; Collet L; Chéry-Croze S
    J Acoust Soc Am; 1996 Oct; 100(4 Pt 1):2228-35. PubMed ID: 8865631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sources of distortion product otoacoustic emissions revealed by suppression experiments and inverse fast Fourier transforms in normal ears.
    Konrad-Martin D; Neely ST; Keefe DH; Dorn PA; Gorga MP
    J Acoust Soc Am; 2001 Jun; 109(6):2862-79. PubMed ID: 11425129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multicomponent acoustic distortion product otoacoustic emission phase in humans. I. General characteristics.
    Moulin A; Kemp DT
    J Acoust Soc Am; 1996 Sep; 100(3):1617-39. PubMed ID: 8817891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dependence of distortion-product otoacoustic emissions on primary levels in normal and impaired ears. II. Asymmetry in L1,L2 space.
    Whitehead ML; Stagner BB; McCoy MJ; Lonsbury-Martin BL; Martin GK
    J Acoust Soc Am; 1995 Apr; 97(4):2359-77. PubMed ID: 7714255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2f1-f2 distortion product otoacoustic emission latency: changes with frequency and level of primaries.
    Wable J; Collet L; Berger-Vachon C; Chéry-Croze S
    Audiology; 1997; 36(2):72-82. PubMed ID: 9099405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Indications of different distortion product otoacoustic emission mechanisms from a detailed f1,f2 area study.
    Knight RD; Kemp DT
    J Acoust Soc Am; 2000 Jan; 107(1):457-73. PubMed ID: 10641654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of primary frequencies ratio on distortion product otoacoustic emissions amplitude. II. Interrelations between multicomponent DPOAEs, tone-burst-evoked OAEs, and spontaneous OAEs.
    Moulin A
    J Acoust Soc Am; 2000 Mar; 107(3):1471-86. PubMed ID: 10738802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for the distortion product frequency place as a source of distortion product otoacoustic emission (DPOAE) fine structure in humans. I. Fine structure and higher-order DPOAE as a function of the frequency ratio f2/f1.
    Mauermann M; Uppenkamp S; van Hengel PW; Kollmeier B
    J Acoust Soc Am; 1999 Dec; 106(6):3473-83. PubMed ID: 10615687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distortion product otoacoustic emission (2f1-f2) amplitude as a function of f2/f1 frequency ratio and primary tone level separation in human adults and neonates.
    Abdala C
    J Acoust Soc Am; 1996 Dec; 100(6):3726-40. PubMed ID: 8969474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dependence of distortion-product otoacoustic emissions on primary levels in normal and impaired ears. I. Effects of decreasing L2 below L1.
    Whitehead ML; McCoy MJ; Lonsbury-Martin BL; Martin GK
    J Acoust Soc Am; 1995 Apr; 97(4):2346-58. PubMed ID: 7714254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Group delays of distortion product otoacoustic emissions in the guinea pig.
    Schneider S; Prijs VF; Schoonhoven R
    J Acoust Soc Am; 1999 May; 105(5):2722-30. PubMed ID: 10335624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Wave and place fixed DPOAE maps of the human ear.
    Knight RD; Kemp DT
    J Acoust Soc Am; 2001 Apr; 109(4):1513-25. PubMed ID: 11325123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Otoacoustic distortion products in adults with normal hearing].
    Simoncelli C; Molini E; Ricci G; Capolunghi B; Alunni N
    Acta Otorhinolaryngol Ital; 1995 Apr; 15(2):80-6. PubMed ID: 8928654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for two discrete sources of 2f1-f2 distortion-product otoacoustic emission in rabbit. II: Differential physiological vulnerability.
    Whitehead ML; Lonsbury-Martin BL; Martin GK
    J Acoust Soc Am; 1992 Nov; 92(5):2662-82. PubMed ID: 1479129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequency responses of two- and three-tone distortion product otoacoustic emissions in Mongolian gerbils.
    Mills DM
    J Acoust Soc Am; 2000 May; 107(5 Pt 1):2586-602. PubMed ID: 10830382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of hearing loss using 2f2-f1 and 2f1-f2 distortion-product otoacoustic emissions.
    Fitzgerald TS; Prieve BA
    J Speech Lang Hear Res; 2005 Oct; 48(5):1165-86. PubMed ID: 16411804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distortion product otoacoustic emissions in human newborns and adults. I. Frequency effects.
    Lasky RE
    J Acoust Soc Am; 1998 Feb; 103(2):981-91. PubMed ID: 9479751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.